CYTOPORE
Live / Registered — Registered and renewed (as of 28 Apr 2017)
What this means for you
Registered since 11 Mar 1997. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Mar 2017).
Record
- Serial number
- 74552677
- Registration number
- 2044195
- Mark type
- Word mark
- Filed
- 25 Jul 1994
- Published for opposition
- 26 Dec 1995
- Registered
- 11 Mar 1997
- Next maintenance due
- 11 Mar 2017
- Attorney of record
- Dyan M. House
Goods and services
- Class 001 — Chemicals: chemicals, namely, beads as micro carriers for use in manufacturing in the pharmaceutical, biological and biotechnological industries
Owner
- CYTIVA SWEDEN AB, UPPSALA, SE
- GE HEALTHCARE BIO-SCIENCES AB, UPPSALA, SE
- GE HEALTHCARE BIOPROCESS R&D AB, UPPSALA, SE
- GE HEALTHCARE BIO-SCIENCES AB, Uppsala, SE
- AMERSHAM PHARMACIA BIOTECH AB, SE-751 84 UPPSALA, SE
- Pharmacia Biotech AB, S-751 82 Uppsala, SE
- Pharmacia Biotech AB, S-751 82 Uppsala, SE
- Pharmacia Biotech AB, S-751 82 Uppsala, SE
Prosecution history
- 11 Mar 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 19 Oct 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Oct 2023 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 19 Oct 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Oct 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Oct 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Oct 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 22 Sept 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Sept 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Sept 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Sept 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Sept 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 30 Sept 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 13 Feb 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Feb 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED